Jason Lettmann - Insider Trading & Ownership

Entity
Individual
Location
C/O Ra Pharmaceuticals, Inc., 87 Cambridgepark Drive, Cambridge, MA
Summary
The estimated net worth of Jason Lettmann is at least $244K dollars as of April 15, 2025. Jason Lettmann is the CHIEF EXECUTIVE OFFICER, Director of ALX ONCOLOGY HOLDINGS INC and owns shares of ALX ONCOLOGY HOLDINGS INC (ALXO) stock worth about $244K.
All Insider Reports
All Insider Reports

Ownership of Jason Lettmann

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALXO ALX ONCOLOGY HOLDINGS INC CHIEF EXECUTIVE OFFICER, Director $244K -$2.48K -1.01% Apr 11, 2025

Insider Transactions Reported by Jason Lettmann:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.